Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

Causal AI reconstructs glioma treatment timelines

May 25, 2026

Researchers used causal machine learning to model time-dependent treatment effects of radiotherapy and chemotherapy in lower-grade gliomas, according to the report summarized as an AI-driven...

RNAbinding protein RBM20 isoform control in health

May 25, 2026

A new study maps how RNA-binding protein RBM20 generates isoform diversity through independent transcription start sites, according to the description provided. The findings connect...

ZNF274 drives lineage switch and fuels CDK7 resistance in pancreatic cancer

May 25, 2026

Researchers identified ZNF274 as a driver of lineage switch programs that contribute to resistance to CDK7-targeted therapy in pancreatic cancer. The report ties ZNF274 to cancer cell phenotypic...

Preterm birth prevention trial tests antenatal N-acetylcysteine

May 25, 2026

A prospective randomized placebo-controlled trial reported in Pediatric Research evaluated antenatal N-acetylcysteine (NAC) supplementation for women facing imminent preterm birth. The study by...

Prognostic nomogram for childhood aplastic anemia on cyclosporine monotherapy

May 25, 2026

Researchers introduced a prognostic nomogram designed for children with aplastic anemia treated with cyclosporine monotherapy, aiming to reduce uncertainty around response trajectories. The model...

Long-term AAV9 gene therapy comparison for SMA

May 25, 2026

A long-term comparative analysis reported outcomes of AAV9-mediated gene replacement therapies in murine models of spinal muscular atrophy, according to the study summary provided. The work...

Sepsis mortality in C. difficile matches other causes

May 25, 2026

A Scientific Reports study found that sepsis associated with Clostridioides difficile (C. difficile) infection carries mortality risk comparable to sepsis from other causes. The result challenges...

AI explainability framework targets injury deaths

May 25, 2026

Researchers described an explainable AI framework designed to address intentional injury mortality—covering suicide and homicide—using a publication highlighted in Scientific Reports. The approach...

AI drug discovery

May 24, 2026

Isomorphic Labs detailed new capabilities for its Isomorphic Labs Drug Design Engine (IsoDDE), positioning the system as a step beyond AlphaFold 3 for real drug discovery tasks. In technical...

Sepsis and infectious disease risk

May 24, 2026

A new Scientific Reports study reports that sepsis associated with Clostridioides difficile infection carries mortality risk comparable to sepsis from other causes. Researchers used the finding to...

AI for clinical decision support

May 24, 2026

Researchers introduced an explainable AI framework aimed at improving recognition of intentional injury mortality, covering both suicide and homicide, reported in Scientific Reports. The approach...

ASCO 2026 pipeline readouts

May 24, 2026

CancerNetwork previewed which trial data may draw attention when the 2026 ASCO Annual Meeting opens. The pre-meeting embargo lift highlighted cost-effectiveness data from the phase 3 CHALLENGE...

Prognostics in rare hematologic disease

May 24, 2026

Researchers unveiled a prognostic nomogram designed for children with aplastic anemia (AA) treated with cyclosporine monotherapy, aiming to address the unpredictable response to treatment. The...

Precision immunotherapy insights in systemic sclerosis

May 24, 2026

A Nature Communications study reported deep profiling of skin remodeling in systemic sclerosis following immunotherapy, using cellular and molecular analyses to map changes in diseased tissue. The...

Oncology: resistance and lineage plasticity

May 24, 2026

Researchers identified a role for the zinc finger protein ZNF274 in blocking lineage switching while also fueling CDK7 drug resistance in cancer models, according to a study described in the...

Cystic fibrosis drug safety in preschoolers

May 24, 2026

An Italian multicenter study reported real-world evidence that lumacaftor/ivacaftor is safe and effective in preschool-aged children with cystic fibrosis carrying relevant genotypes, including...

Renal disease mechanisms

May 24, 2026

Researchers described a kidney-protective mechanism mediated by CD5L, reporting that the protein shields kidneys by reducing cellular oxidative stress. The study outlines how CD5L influences...

AAV gene therapy longevity in SMA

May 24, 2026

A study released a long-term comparative analysis of AAV9-mediated gene replacement therapies in murine spinal muscular atrophy (SMA) models. It compares engineered gene therapy versions over...

Regulatory approvals

May 24, 2026

The FDA cleared Gilead’s hepatitis D therapy Hepcludex (bulevirtide) four years after the agency previously rejected the drug tied to manufacturing and distribution issues. The approval gives...

Oncology pipeline readouts and trial updates

May 24, 2026

ASCO will highlight a wave of pancreatic cancer innovation beyond KRAS, with daraxonrasib’s new data expected to anchor attention. Abstract coverage also points to multiple mechanism classes,...